TIMOTHY YAO: Open Payments
NPI 1760712699 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 20 payments from 14 companies in 2025. Trend: 2023 $917 · 2024 $255 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 3 | $74 |
| Lilly USA, LLC | 3 | $67 |
| BETA BIONICS, INC. | 1 | $53 |
| Amgen Inc. | 2 | $42 |
| Dexcom, Inc. | 1 | $40 |
| Abbott Laboratories | 2 | $39 |
| Sequel Med Tech, LLC | 1 | $32 |
| Mannkind Corporation | 1 | $30 |
| Soleno Therapeutics, Inc. | 1 | $28 |
| KYOWA KIRIN, INC. | 1 | $25 |
Products named: GVOKE HYPOPEN, iLet Bionic Pancreas, JARDIANCE, EVENITY, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, TWIIST, AFREZZA.
Industry payments across CA — which companies pay providers there.
